Institution
Taipei Veterans General Hospital
Healthcare•Taipei, Taiwan•
About: Taipei Veterans General Hospital is a healthcare organization based out in Taipei, Taiwan. It is known for research contribution in the topics: Population & Cancer. The organization has 11878 authors who have published 16478 publications receiving 363424 citations. The organization is also known as: Táiběi Róngmín Zǒngyī Yuàn.
Topics: Population, Cancer, Medicine, Hazard ratio, Atrial fibrillation
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Hot flashes in peri- and postmenopausal women were associated with anxious and depressive symptoms in East Asian population with low prevalence of vasomotor symptoms.
108 citations
••
TL;DR: This method of treating recurrent keloid and hypertrophic scars involves surgical excision associated with intraoperative steroid injection, followed by routine weekly steroid injections for 2-5 weeks dependent on clinical signs and symptoms (pain, pruritus or paraesthesia), and monthly injections for another 3-6 months.
108 citations
•
TL;DR: Investigation of the frequency of cyclin A overexpression and the correlated clinical outcome in human hepatocellular carcinoma (HCC) suggests that overeexpression of cyclIn A can be an independent prognostic factor for the tumor relapse of human HCC.
Abstract: Cyclin A is an S- and G2-M-phase regulatory protein, and its abnormal expression has been implicated in cellular transformation. This work was undertaken to investigate the frequency of cyclin A overexpression and the correlated clinical outcome in human hepatocellular carcinoma (HCC). Herein, 12 of 31 (39%) patients exhibited cyclin A overexpression in their tumorous tissues, resulting from gene amplification in 6 of 12 patients, (post)transcription in 4 of 12 patients, and (post)translation in 2 of 12 patients. Patients who overexpressed cyclin A had significantly more tumor cells in the S and G2-M phases compared with those expressing a normal cyclin A level (P = 0.007 and 0.039, respectively). Increased levels of Skp 2, a cyclin A-interacting protein, were also found in 17 of 31 (55%) of HCC patients who showed a trend to have more S-phase tumor cells (P = 0.07). By an unpaired Student's t test and a Fisher's exact or chi2 analysis, overexpression of cyclin A had a strong correlation with elevated Skp 2 expression and increased alpha-fetoprotein levels (P = 0.001 and 0.009, respectively), but it was not associated with patients' age, tumor size, cirrhosis, or the positive detection of hepatitis B virus surface antigen. In the disease-free survival analysis, patients whose tumors overexpressed cyclin A had a median disease-free survival of 6 months, whereas patients who lacked cyclin A overexpression exhibited a longer median period of 29 months (P = 0.046). The overall survival analysis revealed the same trend, i.e., cyclin A-overexpressing patients had shorter overall survival periods (median, 12 versus 50 months; P = 0.09). By multivariate analysis, the correlation of cyclin A overexpression with shorter disease-free periods remained significant after adjustment for Skp 2 overexpression and alpha-fetoprotein induction (P = 0.019). These data suggest that overexpression of cyclin A can be an independent prognostic factor for the tumor relapse of human HCC.
108 citations
••
TL;DR: It is suggested that hepatitis C virus is transmitted mainly by the parenteral route in Taiwan and transmission from mother to infant is not an important mode of spread of hepatitis Cirus.
108 citations
••
TL;DR: This study elucidates a multistep CRCSC-neutrophil interaction during advanced cancer progression and suggests strategies targeting aberrant neutrophil activation may be developed for combating CSC-related malignancy.
Abstract: Cell-cell interactions maintain tissue homeostasis and contribute to dynamic alteration of the tumor microenvironment (TME). Communication between cancer and host cells not only promotes advanced disease aggression but also determines therapeutic response in cancer patients. Despite accumulating evidence supporting the role of tumor-infiltrating immunocytes in modulating tumor immunity, the interplay between heterogeneous tumor subpopulations and immunocytes is elusive. We expanded colorectal cancer stem cells (CRCSCs) as cancer spheroids from the murine colorectal cancer (CRC) cell line CT26 to interrogate tumor-host interactions using a syngeneic tumor model. RNA-sequencing analysis of host cells and tumor exosomes was performed to identify molecular determinants that mediate the crosstalk between CRCSCs and immunocytes. The Cancer Genome Atlas (TCGA) database was used to validate the clinical significance in CRC patients. The expanded CT26 cancer spheroids showed increased stemness gene expression, enhanced spheroid and clonogenicity potential, and an elevated tumor-initiating ability, characteristic of CRCSCs. By examining immune cell composition in syngeneic tumor-bearing mice, a systemic increase in CD11b+/Ly6GHigh/Ly6CLow neutrophils was observed in mice bearing CRCSC-derived tumors. An increased secretion of CRCSC exosomes was observed in vitro, and through in vivo tracking, CRCSC exosomes were found to be transported to the bone marrow. Moreover, CRCSC exosomes prolonged the survival of bone marrow-derived neutrophils and engendered a protumoral phenotype in neutrophils. Mechanistically, tumor exosomal tri-phosphate RNAs induced the expression of interleukin-1β (IL-1β) through a pattern recognition-NF-κB signaling axis to sustain neutrophil survival. CRCSC-secreted CXCL1 and CXCL2 then attracted CRCSC-primed neutrophils to promote tumorigenesis of CRC cells via IL-1β. Moreover, neutrophil depletion using a Ly6G-specific antibody (clone 1A8) attenuated the tumorigenicity of CRCSCs. In human specimens, CRC patients exhibiting an active CRCSC signal (Snail+IL8+) showed elevated tumor infiltration of MPO+ neutrophils, and high (in the top 10%) MPO expression predicted poor survival of CRC patients. This study elucidates a multistep CRCSC-neutrophil interaction during advanced cancer progression. Strategies targeting aberrant neutrophil activation may be developed for combating CSC-related malignancy.
108 citations
Authors
Showing all 11952 results
Name | H-index | Papers | Citations |
---|---|---|---|
Peng Huang | 95 | 590 | 39098 |
Hui Y. Lan | 86 | 248 | 23383 |
Yau-Huei Wei | 78 | 385 | 22286 |
Chunyu Liu | 76 | 450 | 26738 |
Ching-Yu Cheng | 75 | 541 | 39780 |
Shou-Dong Lee | 75 | 788 | 26066 |
Shih Ann Chen | 73 | 698 | 28441 |
Shuu Jiun Wang | 71 | 502 | 24800 |
Pesus Chou | 65 | 481 | 16907 |
Jong Ling Fuh | 65 | 383 | 19559 |
Shing Jong Lin | 63 | 401 | 13236 |
Charles Y. Chiu | 62 | 236 | 13185 |
Bor-Luen Chiang | 60 | 460 | 13597 |
Tzeng Ji Chen | 60 | 541 | 13644 |
Shih Hwa Chiou | 58 | 262 | 12289 |